Going directly to the final PDF URL works as of right now but the previous URL is probably better in case they publish another revision. The paper is not yet final. Cell.com belongs to Elsevier.
I'm a layperson, on a read through this appears to have content that would a) enable a new testing method for covid that could offer higher throughput than PCR and b) describe functional changes brought about by covid that persist for 120 days beyond the infection that could be implicated in cases of long covid.
"Since mature erythrocytes cannot synthesize new proteins to replace
damaged ones and the average lifespan of erythrocytes is 120 days, the authors hypothesize that the circulation of irreversibly damaged erythrocytes with impaired function could contribute to the long-term effects of COVID-19 (25)"
5 comments
[ 2.6 ms ] story [ 15.5 ms ] threadhttps://www.cell.com/biophysj/pdf/S0006-3495(21)00454-9.pdf
The document contains 32 pages about the subject.
then some javascript shenanigans
then jumps to https://www.biophysj.org/retrieve/pii/S0006349521004549
then to https://www.cell.com/biophysj/retrieve/pii/S0006349521004549
and finally https://www.cell.com/biophysj/pdf/S0006-3495(21)00454-9.pdf
Going directly to the final PDF URL works as of right now but the previous URL is probably better in case they publish another revision. The paper is not yet final. Cell.com belongs to Elsevier.
"Since mature erythrocytes cannot synthesize new proteins to replace damaged ones and the average lifespan of erythrocytes is 120 days, the authors hypothesize that the circulation of irreversibly damaged erythrocytes with impaired function could contribute to the long-term effects of COVID-19 (25)"
So could that end up as a useful treatment? Or would it only help with the WBC, and not the RBC?